Ping An Biomedical Co., Ltd. (PASW)
| Market Cap | 4.67M |
| Revenue (ttm) | 4.80M -61.0% |
| Net Income | -1.80M |
| EPS | -0.10 |
| Shares Out | 20.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 630,913 |
| Open | 0.2295 |
| Previous Close | 0.2379 |
| Day's Range | 0.2061 - 0.2310 |
| 52-Week Range | 0.1607 - 5.4000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 12, 2026 |
About PASW
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China. Its services include market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company offers a range of yarn products, textiles, and finished garments; and real estate property investment and warehousing services. It serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. The com... [Read more]
Financial Performance
In fiscal year 2025, Ping An Biomedical's revenue was 34.15 million, a decrease of -61.03% compared to the previous year's 87.62 million. Losses were -12.83 million, 899.0% more than in 2024.
Financial numbers in CNY Financial StatementsNews
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the “Inv...
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) today announced that it has entered into a series of share purchase ...
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Company”) today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter.
Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting
HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the “Company”) announced that during the Extraordinary General Meeting of Shareholders (the “Meeting”) held to...
Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the “Company”), a provider of SCM services in the apparel industry delivering one-stop solution, today annou...
U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings
Six issuers debuted in the US this past week, led by two mining companies. Three blank check companies also went public, and a handful of notable IPO candidates joined the pipeline. Four sizable IPOs ...
Majestic Ideal Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the “Company”), a provider of SCM services in the apparel industry delivering one-stop solution, today annou...
China-U.S. IPO Train Creeps Ahead With First New Listing Application
China's securities regulator said it has received an application from Majestic Ideal Holdings for a U.S. listing. The notice could indicate a 2-year-old pause in new U.S. listings by Chinese companies...
Majestic Ideal Holdings Readies $17 Million U.S. IPO Plan
Majestic Ideal Holdings has filed proposed terms for a $17 million U.S. IPO. The company provides supply chain management services to apparel industry companies operating in the PRC.